MTCH
59
-7
SNA
55
3
ZION
44
3
BA
44
2
LMT
37
-2
TSCO
62
3
ECL
69
5
DD
48
3
MRK
56
-7
TRV
42
3
RF
37
2
DLTR
47
3
NWS
69
-4
AES
51
-4
GILD
26
-3
UNH
36
-13
HON
57
4
CL
72
3
FE
39
-2
FLR
42
-3
MTCH
59
-7
SNA
55
3
ZION
44
3
BA
44
2
LMT
37
-2
TSCO
62
3
ECL
69
5
DD
48
3
MRK
56
-7
TRV
42
3
RF
37
2
DLTR
47
3
NWS
69
-4
AES
51
-4
GILD
26
-3
UNH
36
-13
HON
57
4
CL
72
3
FE
39
-2
FLR
42
-3
Financhill
Back

KBC Groupe NV Vs. Spyre Therapeutics Industry Stock Comparison

Sell
33

KBCSY
KBC Groupe NV

Last Price:
35.25
Seasonality Move:
-0.38%
Sell
39

SYRE
Spyre Therapeutics

Last Price:
25.33
Seasonality Move:
49.76%
Sell
33
KBC Groupe NV (KBCSY) is a Sell

Is KBC Groupe NV a Buy, Sell or Hold?

  • The current KBC Groupe NV [KBCSY] share price is $35.25. The Score for KBCSY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • KBCSY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics a Buy, Sell or Hold?

  • The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KBCSY Stock Price Chart

What is KBC Groupe NV's stock price today?

  • The KBC Groupe NV share price today is $35.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KBCSY is experiencing buying pressure, which is a positive indicator for future bullish movement.

SYRE Stock Price Chart

What is Spyre Therapeutics's stock price today?

  • The Spyre Therapeutics share price today is $25.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.

KBCSY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.62 Sell
Relative Strength Index (14 RSI): 44.1 Sell
Chaikin Money Flow: 29179 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.29 - 37.21) Sell
Bollinger Bands (100): (34.17 - 37.87) Sell

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.04 Sell
Relative Strength Index (14 RSI): 31.35 Sell
Chaikin Money Flow: -1780910 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.05 - 37.75) Sell
Bollinger Bands (100): (27.4 - 39.18) Sell

KBCSY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.15 Buy
20-day SMA: 35.99 Sell
50-day SMA: 36.82 Sell
200-day SMA: 33.2 Buy
8-day EMA: 35.16 Buy
20-day EMA: 35.83 Sell
50-day EMA: 36.3 Sell
200-day EMA: 34.62 Buy

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.63 Sell
20-day SMA: 34.16 Sell
50-day SMA: 35.1 Sell
200-day SMA: 24.22 Buy
8-day EMA: 32.34 Sell
20-day EMA: 33.91 Sell
50-day EMA: 34.32 Sell
200-day EMA: 27.18 Sell

KBC Groupe NV Earnings Growth & KBCSY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.00 per share.

Spyre Therapeutics Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.

KBC Groupe NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Spyre Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):